Insiders AVROBIO, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-28 pm EDT			5-day change	1st Jan Change
1.48 ^USD	-1.99%		+7.25%	+8.82%

May. 15	Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing	MT
May. 09	AVROBIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing	May. 15	MT
AVROBIO, Inc. Announces Resignation of Geoff Mackay as President	23-05-02	CI
AVROBIO, Inc. Announces CEO Changes	23-05-02	CI
AVROBIO Appoints Erik Ostrowski as Interim Chief Executive	23-05-01	MT
AVROBIO, Inc. Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer	22-02-01	CI
AVROBIO, Inc. Announces Appointment of Essra Ridha as Chief Medical Officer	21-10-26	CI
AVROBIO, Inc. Appoints Diana M. Escolar as Chief Medical Officer	21-01-19	CI
Avrobio, Inc. Appoints Dr. Gail Farfel to Its Board of Directors	20-10-21	CI
AVROBIO, Inc. Announces Executive Changes	20-06-29	CI
AVROBIO Appoints Holly May as Chief Commercial Officer	19-10-22	CI
Avrobio Appoints Georgette Verdin as Chief Human Resources Officer	19-08-26	CI
AVROBIO, Inc. Appoints Georgette Verdin as Chief Human Resources Officer	19-08-16	CI
AVROBIO, Inc. Announces Board Changes	19-01-07	CI
AVROBIO, Inc. Announces Management Changes	18-12-18	CI
AVROBIO, Inc. Announces the Resignation of Joshua Resnick as Member of the Board of Directors	18-09-24	CI
AVROBIO, Inc. Elects Phillip B. Donenberg to Board of Directors	18-06-25	CI
AVROBIO Inc. Appoints Annalisa Jenkins to Board of Directors	18-04-04	CI
AVROBIO, Inc. Appoints Ian Clark to Board of Directors	17-11-09	CI
Avrobio, Inc. Announces Appointment of Katina Dorton as Chief Financial Officer	17-09-26	CI
AVROBIO Inc. Announces Executive Appointments	16-11-09	CI

No results for this search